Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1986 | 1 |
2014 | 1 |
2015 | 1 |
2020 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
Leukemia. 2020 Aug;34(8):2074-2086. doi: 10.1038/s41375-020-0826-9. Epub 2020 May 7.
Leukemia. 2020.
PMID: 32382082
Free PMC article.
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
Haaß W, Kleiner H, Weiß C, Haferlach C, Schlegelberger B, Müller MC, Hehlmann R, Hofmann WK, Fabarius A, Seifarth W; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; German CML Study Group.
Haaß W, et al.
PLoS One. 2015 Jun 18;10(6):e0129648. doi: 10.1371/journal.pone.0129648. eCollection 2015.
PLoS One. 2015.
PMID: 26087013
Free PMC article.
Item in Clipboard
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, Haferlach C, Schlegelberger B, Fabarius A, Seifarth W, Spieß B, Wuchter P, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Burchert A, Brümmendorf TH, Hasford J, Hochhaus A, Saußele S, Baccarani M; SAKK and the German CML Study Group.
Hehlmann R, et al.
Leukemia. 2020 Oct;34(10):2823. doi: 10.1038/s41375-020-01039-7.
Leukemia. 2020.
PMID: 32913312
Free PMC article.
Item in Clipboard
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L, Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M, Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A, Hasford J, Hehlmann R, Saußele S; German Chronic Myeloid Leukemia Study Group; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK).
Proetel U, et al.
Ann Hematol. 2014 Jul;93(7):1167-76. doi: 10.1007/s00277-014-2041-0.
Ann Hematol. 2014.
PMID: 24658964
Free PMC article.
Clinical Trial.
Item in Clipboard
[Multiple recurrences of malignant fibrous histiocytoma with terminal histiocytic character and peritoneal sarcomatosis].
Hill K, Weischer H.
Hill K, et al. Among authors: weischer h.
Pathologe. 1986 Feb;7(2):110-7.
Pathologe. 1986.
PMID: 3010269
German.
No abstract available.
Item in Clipboard
Cite
Cite